Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-10-20
1996-05-07
Mullis, Jeffrey
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514248, 514280, 514284, 514393, 514400, 514724, 568303, 568305, 568308, 568326, C07C 49203, C07C 49115, C07C 4900
Patent
active
055146759
ABSTRACT:
This invention provides methods of treating a physiological disorder associated with an excess of bradykinins in a mammal which comprises administering to a mammal in need of said treatment a compound selected from a series of substituted dihydronaphthalenes and naphthalenes.
REFERENCES:
patent: 4230862 (1980-10-01), Suarez et al.
patent: 5028613 (1991-07-01), Sun et al.
patent: 5059624 (1991-10-01), Monache et al.
patent: 5166161 (1992-11-01), Kokura et al.
patent: 5212165 (1993-05-01), Aberg et al.
patent: 5212182 (1993-05-01), Musser et al.
patent: 5228725 (1994-02-01), Witherup et al.
patent: 5288725 (1994-02-01), Witherup et al.
Bruns, Jr. Robert F.
Gehlert Donald R.
Howbert J. Jeffry
Lunn William H. W.
Boone David E.
Eli Lilly and Company
Gaylo Paul J.
Mullis Jeffrey
LandOfFree
Naphthyl bradykinin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Naphthyl bradykinin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Naphthyl bradykinin receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1227365